Research summary
Probiotics and Skin
Quick answer
Pooled randomized-trial evidence suggests probiotics taken during pregnancy and continued in infancy may lower the chance of atopic dermatitis developing, while evidence for easing already-established atopic dermatitis in children is limited and inconsistent. The best species, doses, and durations remain undefined.[1], [2]
Limitations of the evidence
The available pooled evidence centers on atopic dermatitis (eczema) in infants and children rather than other skin concerns such as acne, where data named in these reviews are sparse. Effects depended heavily on the probiotic strain, the timing of administration, and the population studied, and prevention findings rested largely on combined prenatal-and-postnatal use.[1], [2]
Because the best species, dose, and duration are still undefined and the included trials were heterogeneous, these results should be read as preliminary signals rather than firm guidance. This article is informational and is not medical advice.[1], [2]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In meta-analyses of randomized trials, probiotic supplementation given to mothers during pregnancy and continued in infancy was associated with a lower likelihood of atopic dermatitis occurrence in children at general or high allergy risk. based on pooled randomized trials using combined prenatal-plus-postnatal probiotic administration (often Lactobacillus alone or with Bifidobacterium); postnatal-only use was not protective and benefit is not established for everyone | [1] |
| Evidence that probiotics reduce established atopic dermatitis severity in children is limited and inconsistent, with a small pooled improvement in symptom scores that varied by strain, age, and region and that authors did not consider robustly established. based on a meta-analysis of 13 randomized trials showing only a small mean SCORAD reduction with no significant effect in children under 1 year or in European populations; effect differed by probiotic strain and dose, species, and duration remain undefined | [2] |
| Across these meta-analyses the most efficacious probiotic species, doses, and treatment durations for skin outcomes were not defined, and larger, higher-powered randomized trials were called for. reflects authors' conclusions that current trials are heterogeneous and that species, dose, and duration remain to be identified | [1], [2] |
Prevention of atopic dermatitis
A meta-analysis of 16 randomized studies examined whether giving probiotics could lower the chance that atopic dermatitis (eczema) develops in children. Pooled results were associated with reduced odds of atopic dermatitis occurrence, with protection seen in both general-population and high-allergy-risk groups.[1]
Timing appeared to matter. The protective association was found when probiotics were given to mothers during pregnancy and then continued in infancy, whereas administration only after birth was not associated with a meaningful reduction. Both Lactobacillus alone and Lactobacillus combined with Bifidobacterium were reported as protective in subgroup analyses. This is a population-level signal, not a guarantee of benefit for any individual.[1]
Treating established atopic dermatitis
For children who already have atopic dermatitis, the picture is weaker. A meta-analysis of 13 randomized controlled trials found only a small pooled improvement in symptom severity scores, and the authors stated the research to date had not robustly shown probiotics to be beneficial for children with the condition.[2]
Results varied by strain, age, and region: no significant effect was observed in children under one year of age or in European populations, while some individual strains and mixed-strain products were associated with larger reductions. This heterogeneity means findings should be interpreted with caution.[2]
What the evidence does not yet settle
Both meta-analyses noted that the underlying trials were heterogeneous and that the most effective probiotic species, doses, and treatment durations for skin outcomes have not been defined. The authors called for larger, higher-powered randomized trials before firmer conclusions can be drawn.[1], [2]
References
- Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies.. Journal of the European Academy of Dermatology and Venereology : JEADV. 2015. Systematic review and meta-analysis View source →
- Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Frontiers in cellular and infection microbiology. 2017. Systematic review and meta-analysis View source →
Continue from here
Use the main FAQ hub to place this research summary in context alongside dosing, forms, safety, and product-selection questions.